NM_033380.3:c.1913G>C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_033380.3(COL4A5):c.1913G>C(p.Gly638Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G638R) has been classified as Pathogenic.
Frequency
Consequence
NM_033380.3 missense
Scores
Clinical Significance
Conservation
Publications
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A5 | ENST00000328300.11 | c.1913G>C | p.Gly638Ala | missense_variant | Exon 25 of 53 | 1 | NM_033380.3 | ENSP00000331902.7 | ||
| COL4A5 | ENST00000483338.1 | c.737G>C | p.Gly246Ala | missense_variant | Exon 9 of 20 | 1 | ENSP00000495685.1 | |||
| COL4A5 | ENST00000361603.7 | c.1913G>C | p.Gly638Ala | missense_variant | Exon 25 of 51 | 2 | ENSP00000354505.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
COL4A5-related disorder Pathogenic:1
The COL4A5 c.1913G>C variant is predicted to result in the amino acid substitution p.Gly638Ala. This variant was reported in an individual with Alport syndrome (Boye et al. 1995. PubMed ID: 7599631). Alternative variants at the same codon p.Gly638Val and p.Gly638Ser were also reported in individuals with Alport syndrome (Boye et al. 1995. PubMed ID: 7599631; Table S2, Andrea Domingo-Gallego et al. 2022. PubMed ID: 33532864). This variant has not been reported in a large population database. The p.Gly638Ala residue is located in the triple-helical region (residues 42 – 1456) of the COL4A5 protein (uniprot.org). The majority of pathogenic variants in COL4A5 substitute a glycine residue to a bulkier amino acid in the triple-helical domain (Hudson et al. 1993. PubMed ID: 8253711; https://www.ncbi.nlm.nih.gov/books/NBK1207/). Taken together, we interpret this variant as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at